MONTEBELLO DIAGNOSTICS AS
Score · fiscal year 2025
60of 100
How to read this: the company is ahead of 71 % of medium-sized companies in the same sector in 2025. What does this mean?
Rank: 11,697 of 38,670 · Handel
Profile
Cheetah · Sprinter
High profitability, lower solidity
Position against comparable companies in 2025, not a verdict on the company. Based on profitability 94 and solidity 48 out of 100 among medium-sized companies in the same sector in 2025. Methodology
Against the sector
MONTEBELLO DIAGNOSTICS AS is 11 points above the median for medium-sized companies in the same sector in 2025.
Median score 49 among 2,198 companies.
Against medium-sized companies in the same sector in 2025: operating margin 17.0% (median 3.2%) and equity ratio 31.4% (median 32.6%).
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating revenue | 230 MNOK | 173 MNOK |
| Operating margin | 17.0% | 3.2% |
| Profit margin | 17.0% | 3.2% |
| Return on assets | 36.0% | 11.6% |
| Equity ratio | 31.4% | 32.6% |
| Debt-to-equity | 2.18 | 2.03 |
| Current ratio | 1.42 | 1.38 |
| Revenue growth | −0.8% | 6.8% |
| Revenue per employee | 28.73 MNOK | 6.45 MNOK |
The median and “ahead of” refer to medium-sized companies in the same sector in 2025. The bar shows the share of companies the figure is ahead of.
With an index of 60, MONTEBELLO DIAGNOSTICS AS does better than 71% of medium-sized companies in the same sector (2,203 companies) in 2025.
Score 2023–2025
- MONTEBELLO DIAGNOSTICS AS
- Median: medium-sized companies in the same sector
MONTEBELLO DIAGNOSTICS AS has a score of 60 for 2025, rank 11,697 of 38,670 in the sector.
Strongest: Profitability: percentile 94 against peers, operating margin 17.0% against a median of 3.2%.
Weakest: Growth: percentile 24 against peers, revenue growth −0.8% against a median of 6.8%.
Worth a closer look
- What lies behind weak growth, and will it last?
Written by fixed rules from the figures. Describes the figures, does not explain causes. Not investment or financial advice. How the summary is made
What the numbers say
MONTEBELLO DIAGNOSTICS AS had an operating margin of 17.0% and an equity ratio of 31.4% in 2025, and ranks 11,697 of 38,670 in Handel.
No large changes in the key figures from 2024 to 2025.
This text is generated automatically from the 2025 accounts.
Three simple methods
The methods give between 34 MNOK and 333 MNOK.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 10.0 | 305 MNOK |
| EV/EBIT | 8.0 | 333 MNOK |
| P/B | 1.0 | 34 MNOK |
A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation
Worth a closer look
No rules were triggered for this year.
Indications based on the latest annual accounts from open data. Not investment or financial advice.
Financial costs were 0.5% of the debt in 2025. The policy rate averaged 4.30 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.
Data quality
No anomalies found in the figures.
Scenario analysis: the sector's weakest year
We have no accounts for 2017, the sector's weakest year, for this company.
The sector's weakest year was 2017, with a median operating margin of −65.6%. Based on the 11 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
What the score is made of
| Profitability | 94 | weight 30% |
|---|---|---|
| Solidity | 48 | weight 25% |
| Liquidity | 53 | weight 15% |
| Growth | 24 | weight 15% |
| Consistency | 52 | weight 15% |
Durability: 62 (average over 3 years)
Index version 2. Data completeness 100%: the share of the weights that had data.
Questions and answers
How profitable is MONTEBELLO DIAGNOSTICS AS?
The operating margin was 17.0% in 2025, against a median of 3.2% among medium-sized companies in the same sector. Return on assets was 36.0%.
How solid is MONTEBELLO DIAGNOSTICS AS?
The equity ratio was 31.4% in 2025 (median 32.6%). Debt-to-equity was 2.18 (median 2.03).
What is the liquidity of MONTEBELLO DIAGNOSTICS AS like?
The current ratio was 1.42 in 2025 (median 1.38).
How does MONTEBELLO DIAGNOSTICS AS compare in Handel?
MONTEBELLO DIAGNOSTICS AS ranks 11,697 of 38,670 in Handel for 2025. Among companies of the same size (medium-sized companies) it ranks 643 of 2,203. Revenue changed by −0.8% from the year before.
Public contracts
- Contracts awarded since 2024
- 9
- in 8 notices (lots counted separately)
- Total awarded value since 2024
- 0.8 MNOK
- 4 contracts without a stated value are not in the total.
- Framework agreements
- 4
- Left out of the total: the value is a ceiling, not actual spend.
Based on notices in Doffin. Does not show call-offs under framework agreements or purchases below the publication threshold. Values are as stated by the buyer.
Source: Doffin (DFØ), fetched 28 October 2026. Winners are matched on organisation number.
Contains data under the Norwegian licence for public data (NLOD 2.0) made available by Doffin/the Norwegian Agency for Public and Financial Management (DFØ). NLOD 2.0
From the Central Coordinating Register
- Org. no.
- 994171127
- Legal form
- AS
- Sector
- Handel (46.460)
- Size tier
- medium
- Employees
- 8 registered 10 April 2026
- Founded
- 28 April 2009 17 years in operation
- Share capital
- 0.10 MNOK
- Business address
- 3. etg, Ole Deviks vei 16, 0666 OSLO
- Municipality
- Oslo rank 63–221 of 357 in Norway
- Latest accounts filed
- 2025
- Website
- www.montebello.no
- LEI
- 635400FNJEIVNILUBU13 renews 3 March 2021
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Ownership and roles
- Chief executive
- John Mikael Søderberg
- Chair of the board
- Arnhild Stensrud
- Board member
- John Mikael Søderberg
- Board member
- Lene Therese Olsen Hult
- Board member
- Ingrid Frivold Brobakk
- Board member
- Halldor Christen Tjoflaat
- Auditor
- SLM REVISJON AS
- Accountant
- TEMA REGNSKAP OSLO AS
Source: Central Coordinating Register, fetched 29 October 2026. Only names are shown.
Owners and shareholdings will appear here once the shareholder data extract is in place.
Coming · not built yet
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Figures last fetched 29 October 2026.
Year by year · 2023–2025
| Key figure | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Index | 53 | 72 | 60 | |
| Rank | 15,243 | 3,980 | 11,697 | |
| Operating margin | 8.0% | 16.6% | 17.0% | |
| Return on assets | 16.3% | 36.3% | 36.0% | |
| Equity ratio | 24.9% | 31.2% | 31.4% | |
| Current ratio | 1.26 | 1.41 | 1.42 | |
| Revenue growth | – | 58.5% | −0.8% |
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (NOK).
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | 146.1 MNOK | 231.7 MNOK | 229.9 MNOK |
| Operating profit | 11.7 MNOK | 38.4 MNOK | 39.1 MNOK |
| Profit before tax | 10.5 MNOK | 39.9 MNOK | 39.2 MNOK |
| Net profit | 7.9 MNOK | 31.4 MNOK | 30.5 MNOK |
| Financial expenses | 1.4 MNOK | 0.2 MNOK | 0.3 MNOK |
| Total assets | 72.8 MNOK | 110.6 MNOK | 109.7 MNOK |
| Current assets | 68.6 MNOK | 107.3 MNOK | 107.0 MNOK |
| Equity | 18.1 MNOK | 34.5 MNOK | 34.5 MNOK |
| Retained earnings | 17.3 MNOK | 28.7 MNOK | 28.7 MNOK |
| Total liabilities | 54.7 MNOK | 76.1 MNOK | 75.2 MNOK |
| Current liabilities | 54.7 MNOK | 76.1 MNOK | 75.2 MNOK |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 29 October 2026, accounts id 6422751.
Further
Similar companies
- EGGEDAL SAG AS index 60, rank 11,659 · compare
- MERCK AS index 60, rank 11,669 · compare
- NORWEGIAN TOY IMPORT AS index 60, rank 11,685 · compare
- FAMILIEHYTTA AS index 60, rank 11,745 · compare
- VINGMED AS index 60, rank 11,753 · compare